In schizophrenia, altered cognitive and affective functions as well as reduced dendritic spine density and diminished synaptic connectivity have been described. The cytoskeleton plays a key role in maintaining axon and dendrite structure as well as the synaptic connections. In this review we will describe evidence supporting that schizophrenia is a cytoskeletal disease. In addition, we will describe current data indicating that microtubule associated proteins are implicated in the abnormal dendrite structure and the lost of synaptic connectivity. Evidence presented here indicates that the cytoskeleton could be a target for drug therapy in shizophrenia.
In schizophrenia, altered cognitive and affective functions as well as reduced dendritic spine density and diminished synaptic connectivity have been described to occur in the prefrontal cortex and in the limbic system. A brain structure, that plays a key role in affective and cognitive physiology (Garey et al., 1998; Dwork et al., 2005) . The cytoskeleton participates in neural morphology and in the highly structural polarization of axons and dendrites. Also, it has been shown that (Garey et al., 1998; Dwork et al., 2005) . In particular, microtubules 
